Neil Johnson discloses 6.2% Syra Health (SYRA) ownership stake

Rhea-AI Filing Summary

Syra Health Corp shareholder Neil Johnson filed a Schedule 13D reporting beneficial ownership of 700,312 shares of Class A common stock, representing 6.2% of the company. Johnson, an individual based in Ohio who works in consulting, acquired the position using personal funds. The filing notes that his purpose of transaction is "Influence," indicating he may seek to play an active role in matters affecting the company.

The disclosure also shows that on January 13, 2026, Johnson was involved in a transaction for 38,182 shares at a price of $0.085 per share. He reports sole voting power over 700,312 shares, with no shared voting or dispositive power, and no disclosed contracts or arrangements related to these securities.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

Syra Health Corp

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

0001922335

(CUSIP Number)

Neil Johnson
88 E Broad St Suite 1750, Columbus
Columbus OH 43215, OH, 43215
6144481304

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

01/13/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 0001922335

1

Name of reporting person

Johnson Neil Lawrence

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

OHIO

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 700,312.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

700,312.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

6.2 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Class A Common Stock
(b)	Name of Issuer: Syra Health Corp
(c)	Address of Issuer's Principal Executive Offices: 1119 KEYSTONE WAY N., #201, CARMEL, INDIANA , 46032.
Item 2.	Identity and Background
(a)	Neil Johnson
(b)	88 E Broad St Suite 1750 Columbus OH 43215
(c)	Consulting
(d)	No
(e)	No
(f)	US
Item 3.	Source and Amount of Funds or Other Consideration
	Personal Funds
Item 4.	Purpose of Transaction
	Influence
Item 5.	Interest in Securities of the Issuer
(a)	700,312 6.2%
(b)	700,312
(c)	Neil Johnson 1/13/2026 38,182 $0.085
(d)	N/A
(e)	N/A
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	None
Item 7.	Material to be Filed as Exhibits.
	N/A

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Johnson Neil Lawrence

Signature:	Neil L Johnson
Name/Title:	Neil Johnson Individual
Date:	01/16/2026

FAQ

What does the Schedule 13D filing disclose about SYRA ownership?

The filing shows that Neil Johnson beneficially owns 700,312 shares of Syra Health Corp Class A common stock, representing 6.2% of the outstanding class.

Who is the reporting person in the Syra Health (SYRA) Schedule 13D?

The reporting person is Neil Johnson, an individual based in Ohio who lists his occupation as consulting and his citizenship as U.S..

How did Neil Johnson fund his Syra Health (SYRA) share purchases?

Neil Johnson states that the Syra Health shares were acquired using personal funds, as indicated under the source of funds section marked "PF."

What is Neil Johnson’s stated purpose for holding Syra Health (SYRA) shares?

Under the purpose of transaction section, Neil Johnson lists his purpose as "Influence", suggesting an intent to be active in matters related to Syra Health Corp.

Did the Schedule 13D show any recent transactions in Syra Health (SYRA) shares?

Yes. The filing reports that on January 13, 2026, Neil Johnson was involved in a transaction for 38,182 shares at a price of $0.085 per share.

What voting power does Neil Johnson report over Syra Health (SYRA) stock?

He reports sole voting power over 700,312 shares, and no shared voting or dispositive power over Syra Health Corp Class A common stock.